Acceptably derived embryonic stem cell lines
Acceptably derived embryonic stem cell lines
Title 17 California Code of Regulations Section 100080(f) designates all human pluripotent stem cell lines derived in accordance with the CIRM regulations as “acceptably derived.” These cell lines may be used in CIRM funded research.
CIRM has received and reviewed a Certification Form for Human Pluripotent Stem Cell Line Derivation for the lines identified below. Based on the certification provided by the individuals or organization, CIRM designates the line as “acceptably derived.” Summary information regarding the specific cell line is provided below. Additional information may be obtained by contacting the individual(s) indentified below.
See the online draft version of the NIH Request for Human Embryonic Stem Cell Line to be Approved for Use in NIH Funded Research.
Human Stem Cell Lines Determined to be “Acceptably Derived” by CIRM
Line name |
Contact |
Derivation source |
Derivation Date |
Link to donor |
Donor medical history |
Comments |
multiple lines See certification form | Leslie Thompson lmthomps@uci.edu |
iPS | 2009-2011 | yes | yes |
|
UCLA10 | Steve Peckman speckman@mednet.ucla.edu |
Surplus IVF-embryo | 2011 | yes | yes |
|
UCLA 7 | Steve Peckman speckman@mednet.ucla.edu |
Surplus IVF-embryo | 2011 | yes | yes |
|
UCLA6 | Steve Peckman speckman@mednet.ucla.edu |
Surplus IVF-embryo | 2010 | yes | yes |
|
UCLA5 | Steve Peckman speckman@mednet.ucla.edu |
Surplus IVF-embryo | 2010 | yes | yes |
|
UCLA4 | Steve Peckman speckman@mednet.ucla.edu |
Surplus IVF-embryo | 2010 | yes | yes |
|
UCLA3 |
Steve Peckman |
Surplus IVF-embryo |
2009 |
yes |
yes |
|
UCLA2 |
Steve Peckman |
Surplus IVF-embryo |
2009 |
yes |
yes |
|
UCLA1 |
Steve Peckman |
Surplus IVF-embryo |
2009 |
yes |
yes |
|
UCSF3 |
Nick Larocque |
Surplus IVF-embryo |
2009 |
yes |
yes |
|
UCSF4 |
Nick Larocque |
Surplus IVF-embryo |
2009 |
yes |
yes |
|
UCSFB-1 |
Nick Larocque
|
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-2 |
Nick Larocque
|
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-3 |
Nick Larocque
|
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-4 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-5 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-6 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-7 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-8 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-9 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
UCSFB-10 |
Nick Larocque |
Surplus IVF-embryo |
2008 |
yes |
yes |
|
Latest Press Releases
CIRM-funded research programs are helping turn stem cells into cures. Browse our press release archive below to find out the latest advances. For even more breaking news, visit our blog, The Stem Cellar.
-
Mar 27, 2023
-
Feb 27, 2023
-
Jan 26, 2023
-
Dec 15, 2022
Workshop Reports
CIRM holds regular scientific workshops and meetings to update the scientific staff and CIRM grantees about particular areas of stem cell and related research.
- Engineering Strategies, Opportunities, and Challenges for Tissue Repair and Regeneration: CIRM Workshop Summary and Recommendati [pdf]
- Cell Therapies for Parkinson’s Disease from Discovery to Clinic [pdf]
- Alpha Stem Cell Clinics: Delivering a New Kind of Medicine [pdf]
- Cerebral Palsy Workshop Report [pdf]